As a member of Polski Związek Pracodawców Przemysłu Farmaceutycznego (PZPPF) and Medicine for Europe, Gedeon Richter Polska Sp. z o.o. fully respects the requirements of the Code of Conduct which sets out the rules for disclosing information about cooperation between companies and healthcare professionals/healthcare organisations. This cooperation is essential for further development of medicine, and the transparency of these relationships is to improve a positive image and cooperation between pharmaceutical companies, healthcare professionals and healthcare organisations.
Other press releases Gedeon Richter and Sumitomo Pharma Receive Positive CHMP Opinion for RYEQO ® for Treatment of Endometriosis 28/09/2023 IQ Medical and Richter announce the sale and purchase of Giskit MD B.V. 20/07/2023 Transparency Report 2022 11/07/2023 See all press releases
Drugalert Medical information and adverse drug reaction reporting. tel: +48 22 755 96 48 lekalert@grodzisk.rgnet.org
Drugs safety Patient safety is the most important value for the Gedeon Richter Group. Thus monitoring adverse drug events occurring during pharmacotherapy is especially important for us. We offer to patients and physicians current medical information as well as we answer all questions regarding the safety of medicinal products. See all press releases